JP2005537296A5 - - Google Patents

Download PDF

Info

Publication number
JP2005537296A5
JP2005537296A5 JP2004525996A JP2004525996A JP2005537296A5 JP 2005537296 A5 JP2005537296 A5 JP 2005537296A5 JP 2004525996 A JP2004525996 A JP 2004525996A JP 2004525996 A JP2004525996 A JP 2004525996A JP 2005537296 A5 JP2005537296 A5 JP 2005537296A5
Authority
JP
Japan
Prior art keywords
halogen
sealed container
alkyl
alkoxy
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004525996A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005537296A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/018944 external-priority patent/WO2004012653A2/en
Publication of JP2005537296A publication Critical patent/JP2005537296A/ja
Publication of JP2005537296A5 publication Critical patent/JP2005537296A5/ja
Pending legal-status Critical Current

Links

JP2004525996A 2002-06-17 2003-06-17 デヒドロエピアンドロステロンの噴霧器製剤及びその組成物を使用することでの喘息又は慢性閉塞性肺疾患を治療するための方法 Pending JP2005537296A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38924202P 2002-06-17 2002-06-17
US47798703P 2003-06-11 2003-06-11
PCT/US2003/018944 WO2004012653A2 (en) 2002-06-17 2003-06-17 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof

Publications (2)

Publication Number Publication Date
JP2005537296A JP2005537296A (ja) 2005-12-08
JP2005537296A5 true JP2005537296A5 (https=) 2006-08-10

Family

ID=29740120

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004525996A Pending JP2005537296A (ja) 2002-06-17 2003-06-17 デヒドロエピアンドロステロンの噴霧器製剤及びその組成物を使用することでの喘息又は慢性閉塞性肺疾患を治療するための方法
JP2004512683A Pending JP2005530820A (ja) 2002-06-17 2003-06-17 二水和デヒドロエピアンドロステロン及びその組成物を用いた喘息又は慢性閉塞性肺疾患の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2004512683A Pending JP2005530820A (ja) 2002-06-17 2003-06-17 二水和デヒドロエピアンドロステロン及びその組成物を用いた喘息又は慢性閉塞性肺疾患の治療方法

Country Status (11)

Country Link
US (1) US20090087389A1 (https=)
EP (2) EP1553954A4 (https=)
JP (2) JP2005537296A (https=)
KR (2) KR101005819B1 (https=)
CN (2) CN1681520A (https=)
AU (2) AU2003276836B2 (https=)
BR (2) BR0311885A (https=)
CA (2) CA2491846A1 (https=)
IL (2) IL165378A0 (https=)
MX (2) MXPA04012720A (https=)
WO (2) WO2003105775A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2298315A1 (en) * 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Therapeutic treatment methods
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
US7858607B2 (en) * 2003-03-14 2010-12-28 Mamchur Stephen A System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
JP2008543806A (ja) * 2005-06-17 2008-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器疾患の治療のためのｍｒｐｉｖインヒビター
GB0520794D0 (en) * 2005-10-12 2005-11-23 Innovata Biomed Ltd Inhaler
EP2010153A2 (en) * 2006-04-03 2009-01-07 Teva Pharmaceutical Industries Limited Drug microparticles
AU2008259768B2 (en) * 2007-06-05 2013-08-29 Paka Pulmonary Pharmaceuticals, Inc. Compositions for delivering medicaments into the lungs, uses thereof
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ，インコーポレイテッド 胃腸疾患を治療するための方法
WO2010068754A2 (en) 2008-12-10 2010-06-17 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) * 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
WO2014172706A1 (en) * 2013-04-19 2014-10-23 University Of Houston System Cocrystalline dhea formulations
WO2025076250A1 (en) * 2023-10-04 2025-04-10 The Trustees Of Indiana University Slow-release compositions and methods for inflammatory airway obstruction

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943987A (en) * 1974-10-17 1976-03-16 Rossi Thomas J Reclosable air-tight containers with evacuation means
US4379842A (en) * 1980-02-13 1983-04-12 Hoffmann-La Roche Inc. Process for the manufacture of 1α-hydroxydehydroepiandrosterone
US4393066A (en) * 1981-06-05 1983-07-12 Garrett David M Method for treatment of herpetic lesions
US4499064A (en) * 1982-06-03 1985-02-12 Clayton Foundation For Research Assessment of nutritional status of individuals
US4518595A (en) * 1983-07-19 1985-05-21 The Jackson Laboratory Method for treating diabetes using DHEA compounds
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
US4628052A (en) * 1985-05-28 1986-12-09 Peat Raymond F Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
JPS63104924A (ja) * 1986-10-20 1988-05-10 Kanebo Ltd 膣坐剤
NL194728C (nl) * 1987-04-16 2003-01-07 Hollis Eden Pharmaceuticals Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
CH673459A5 (https=) * 1987-05-15 1990-03-15 Eprova Ag
DE58902094D1 (de) * 1988-01-28 1992-10-01 Koeltringer Peter Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
FR2631828B1 (fr) * 1988-05-27 1994-05-20 Spiral Recherche Developpement Utilisation d'une substance folinique en tant qu'agent antiagregant plaquettaire
US4931441A (en) * 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
US4920115A (en) * 1988-12-28 1990-04-24 Virginia Commonwealth University Method of lowering LDL cholesterol in blood
US5077284A (en) * 1988-12-30 1991-12-31 Loria Roger M Use of dehydroepiandrosterone to improve immune response
US5407684A (en) * 1988-12-30 1995-04-18 Virginia Commonwealth University Use of DHEA as a medicinal
IT1229517B (it) * 1989-01-31 1991-09-03 Bioresearch Spa Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
NL8901432A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.
US4985443A (en) * 1989-08-04 1991-01-15 Montes Leopoldo F Method and composition for treating vitiligo
US5173488A (en) * 1989-08-21 1992-12-22 American Cyanamid Company Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
US5270305A (en) * 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
US5110810A (en) * 1991-02-08 1992-05-05 Virginia Commonwealth University Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of platelet aggregation
US5162198A (en) * 1991-02-08 1992-11-10 Virginia Commonwealth University Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of thrombuxane production and platelet aggregation
US5266312A (en) * 1992-01-07 1993-11-30 National Jewis Center For Immunology And Respiratory Medicine Method for treating a steroid resistant condition via administration of gamma interferon
ATE193447T1 (de) * 1992-02-24 2000-06-15 Univ East Carolina Verfahren zur hemmung der karzinogenese durch behandlung mit dehydroepiandrosteron und dessen analoge
US6093706A (en) * 1992-03-04 2000-07-25 Bioresponse, L.L.C. Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
US5686438A (en) * 1993-03-09 1997-11-11 University Of Utah Research Foundation Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
SK286051B6 (sk) * 1993-01-19 2008-02-05 Endorecherche Inc. Použitie prekurzora pohlavného steroidu na prípravu liečiva na prevenciu alebo liečenie znížených alebo nevyrovnaných koncentrácií pohlavných steroidov
US5635496A (en) * 1993-03-09 1997-06-03 University Of Utah Research Foundation Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
US5811418A (en) * 1993-03-09 1998-09-22 University Of Utah Research Foundation Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
ATE283052T1 (de) * 1993-03-09 2004-12-15 Univ Utah Res Found Verwendung von dhea oder dessen derivate zur herstellung eines medikaments zur vorbeugung von progressiver gewebe-nekrose, reperfusionsschädigung, bakterieller translokation und vom atemnotsyndrom bei erwachsenen
US5407927A (en) * 1993-04-16 1995-04-18 The Regents Of The University Of California Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone
EP0796112A4 (en) * 1994-11-30 1999-12-01 Amur Research Corp MEDICINAL DERIVATIVES OF PHOSPHOCHOLIN
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
US5859000A (en) * 1995-06-07 1999-01-12 University Of Utah Research Foundation Method for reducing mast cell mediated allergic reactions
US5767278A (en) * 1995-10-06 1998-06-16 Geron Corporation Telomerase inhibitors
EP1806131A3 (en) * 1996-07-22 2007-08-01 Renovo Limited Use of sex steroid function modulators to treat wounds and fibrotic disorders
US5861391A (en) * 1997-01-29 1999-01-19 Research Development Foundation Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease
US20030013772A1 (en) * 2000-02-23 2003-01-16 Murphy Michael A. Composition, synthesis and therapeutic applications of polyamines
AU763307B2 (en) * 1998-02-04 2003-07-17 Charlotte-Mecklenburg Hospital Authority Androsterone derivatives for inhibiting DNA binding of AP-1 and airway smooth muscle proliferation
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
PL200941B1 (pl) * 1998-11-13 2009-02-27 Jagotec Ag Suchy proszkowy preparat inhalacyjny
RU2220727C2 (ru) * 1999-03-18 2004-01-10 Дженелабс Текнолоджис, Инк. Композиция, содержащая дегидроэпиандростерон, и способы ее изготовления и применения
US6428769B1 (en) * 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration
US20020010128A1 (en) * 2000-04-13 2002-01-24 Parks Thomas P. Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
US7381713B2 (en) * 2000-12-04 2008-06-03 Sioan-Kettering Institute For Cancer Research Treatment of cancer by reduction of intracellular energy and pyrimidines
US20050070487A1 (en) * 2001-04-24 2005-03-31 Nyce Jonathan W. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
US20030216329A1 (en) * 2001-04-24 2003-11-20 Robinson Cynthia B. Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s)
US20030138434A1 (en) * 2001-08-13 2003-07-24 Campbell Robert L. Agents for enhancing the immune response
US7405207B2 (en) * 2002-06-17 2008-07-29 Epigenesis Pharmaceuticals, Inc. Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof

Similar Documents

Publication Publication Date Title
JP2005537296A5 (https=)
JP3717925B2 (ja) 副甲状腺ホルモンの活性フラグメントの肺導入
JP4262086B2 (ja) エーロゾル化用に至適化されたトブラマイシン製剤
US6297227B1 (en) Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
JP2002519318A5 (https=)
JP2003313128A (ja) 気道流路および肺疾患の処置のためのモメタゾンフロエートの使用
JP2001518518A (ja) 分泌性白血球プロテアーゼインヒビターの乾燥粉末薬学的組成物
KR20140069091A (ko) 기침 및 기침으로 인한 발작 치료
JP2017528479A (ja) Ｒｐｌ５５４を含む液体吸入製剤
JP2010503731A (ja) 肺サーファクタント製剤および粘液クリアランスの促進方法
JP2002532520A (ja) 気道病治療および気道用薬剤送達のための化合物および方法
JP6866296B2 (ja) ポリペプチド治療及びその使用
US20250387468A1 (en) Methods and Compositions for Treating Infections
CA2354576C (en) Pharmaceutical preparation for inhalation of an opioid
JP2008513444A (ja) リドカイン及び他の局所麻酔剤の標的運搬並びに咳そう及び咳の発作の処置のための方法
WO2022235621A1 (en) Methods for treating a pulmonary disease with an alk-5 (tgf beta r1) inhibitor
ES2837040T3 (es) Una composición farmacéutica que contiene budesonida y formoterol
CA2827299A1 (en) Liquid propellant-free formulation comprising an antimuscarinic drug
Dongare et al. An overview of recently published patents on pulmonary drug delivery devices
JPH10500966A (ja) 経口吸入もしくは吹き込みにより投与する為の化合物、及び組成物
WO2023150375A2 (en) Methods and compositions for treating covid infections
US20220202699A1 (en) Compositions for the treatment of viral pulmonary infections
EP4699604A1 (en) Inhaled adenovirus vector vaccine, preparation method therefor and use thereof
JP2004503487A (ja) 噴霧化に適した新規な医薬製剤
WO2022234562A1 (en) Ceftriaxone compositions for inhalation and uses thereof